Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3629-3634

  Liu, He ^a   Moy, Peggy ^a   Kim, Sae ^a   Xia, Yan ^a   Rajasekaran, Ayyappan ^a   Navarro, Vincent ^a   Knudsen, Beatrice ^a   Bander, Neil H ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CHROMOSOME MAP; CROSS REACTION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE TARGETING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BINDING, COMPETITIVE; BLOTTING, WESTERN; CROSS REACTIONS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUTAMATE CARBOXYPEPTIDASE II; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY;

EID: 0030866116     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Horoszewicz, J. S., Kawinski, E., and Murphy, G. P. Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients. Anticancer Res., 7: 927-936, 1987.
2. Israeli, R. S., Powell, C T., Fair, W. R., and Heston, W. D. W. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.
3. Rinker-Schaeffer, C. W., Hawkins, A. L., Su, S. L., Israeli, R. S., Griffin, C. A., Isaacs, J. T., and Heston, W. D. W. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics, 30: 105-108, 1995.
4. Lopes, D., Davis, Wendy, L., Rosenstraus, M. J., Uveges, A. J., and Gilman, S. C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res., 50: 6423-6429, 1990.
5. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R., and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
6. Wright, G. L., Jr., Haley, C., Beckett, M. L., and Schellhammer, P. F. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol. Oncol., 1: 18-28, 1995.
7. Diamond, S. M., Fair, W. R., and Heston, W. D. W. Modulation of prostate specific membrane antigen (PSM) expression in vitro by cytokines and growth factors. Proc. Am. Assoc. Cancer Res., 36: 643, 1995.
8. 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356). Prostate, 18: 229-241, 1991.
9. Murphy, G. P. Radioscintiscanning of prostate cancer. Cancer 75 (Suppl.): 1819-1833, 1995.
10. 111indium-labeled monoclonal antibody CYT-356. J. Urol., 152: 1952-1955, 1994.
11. 111indium-labeled CYT-356 for the detection of occult prostate cancer recurrence. J. Urol., 152: 1490-1495, 1994.
12. Troyer, J. K., Feng, Q., Beckett, M. L., and Wright, G. L., Jr. Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen. Urol. Oncol., 1: 29-37, 1995.
13. Troyer, J. K., Beckett, M. L., and Wright, G. L., Jr. Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line. Prostate, 30: 232-242, 1997.
14. Rochon, Y. P., Horoszewicz, J. S., Boynton, A. L., Holmes, E. H., Barren, R. J., III, Erickson, S. J., Kenny, G. M., and Murphy, G. P. Western Blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. Prostate, 25: 219-223, 1994.
15. Rajasekaran, A. K., Hojo, M., Huima, T., and Rodriguez-Boulon, E. Catenins and Zonula Occludens-1 form a complex during early stages in the assembly of tight junctions. J. Cell Biol., 132: 451-463, 1996.
16. Troyer, J. K., Beckett, M. L., and Wright, G. L., Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int. J. Cancer, 62: 552-558, 1995.
17. Silver, D. A., Pellicer, I., Fair, W. R., Heston, W. D. W., and Cordon-Cardo, C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res., 3: 81-85, 1997.
18. Barren, R. J., III, Holmes, E. H., Boynton, A. L., Misrock, S. L., and Murphy, G. P. Monoclonal antibody 7E11.C5 staining of viable LNCaP cells. Prostate, 30: 65-68, 1997.
19. Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C. H., Lin, S., Tong, W. P., May, F., Mukherjee, B., and Heston, W. D. W. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin. Cancer Res., 2: 1445-1451, 1996.
20. Carter, R. E., Feldman, A. R., and Coyle, J. T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA, 93: 749-753, 1996.